Solara Active Pharma Sciences Limited (SOLARA.NS)
INR 517.95
(1.61%)
INR 517.95
(1.61%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 14.09 Billion INR | 0.9% |
| 2022 | 13.96 Billion INR | -2.02% |
| 2021 | 14.25 Billion INR | 39.63% |
| 2020 | 10.2 Billion INR | -3.99% |
| 2019 | 10.63 Billion INR | 6.35% |
| 2018 | 9.99 Billion INR | -5.06% |
| 2017 | 10.53 Billion INR | 31911263.64% |
| 2016 | 33 Thousand INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 12.01 Billion INR | 228.24% |
| 2024 Q1 | -9.36 Billion INR | -166.46% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 14.09 Billion INR | 0.9% |
| 2023 Q4 | 14.09 Billion INR | 0.0% |
| 2023 Q2 | 14.09 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 13.65 Billion INR | 0.0% |
| 2022 FY | 13.96 Billion INR | -2.02% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 13.96 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 14.25 Billion INR | 39.63% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 13.88 Billion INR | 0.0% |
| 2021 Q4 | 14.25 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 10.2 Billion INR | -3.99% |
| 2020 Q4 | 10.2 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 10.57 Billion INR | 0.0% |
| 2019 Q2 | 10.78 Billion INR | 0.0% |
| 2019 FY | 10.63 Billion INR | 6.35% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 10.63 Billion INR | 54.34% |
| 2019 Q3 | 6.88 Billion INR | -36.13% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 9.99 Billion INR | -5.06% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 10.85 Billion INR | 0.0% |
| 2018 Q4 | 9.99 Billion INR | 0.0% |
| 2017 Q4 | 10.53 Billion INR | 17.21% |
| 2017 Q3 | 8.98 Billion INR | 0.0% |
| 2017 FY | 10.53 Billion INR | 31911263.64% |
| 2016 FY | 33 Thousand INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hester Biosciences Limited | 3.59 Billion INR | -292.014% |
| RPG Life Sciences Limited | 1.38 Billion INR | -920.997% |
| Suven Pharmaceuticals Limited | 2.03 Billion INR | -592.734% |
| Ipca Laboratories Limited | 33.74 Billion INR | 58.238% |
| Aarti Drugs Limited | 11.5 Billion INR | -22.495% |
| Aarti Pharmalabs Limited | 8.25 Billion INR | -70.795% |
| Albert David Limited | 1.15 Billion INR | -1125.262% |
| Alembic Limited | 1.43 Billion INR | -883.996% |
| Alkem Laboratories Limited | 48.6 Billion INR | 71.008% |
| Alembic Pharmaceuticals Limited | 16.27 Billion INR | 13.408% |
| Bafna Pharmaceuticals Limited | 652.27 Million INR | -2060.395% |
| Bajaj HealthCare Limited | 4.86 Billion INR | -189.498% |
| Biofil Chemicals and Pharmaceuticals Limited | 288.79 Million INR | -4779.449% |
| Brooks Laboratories Limited | 248.6 Million INR | -5568.441% |
| Eris Lifesciences Limited | 38.26 Billion INR | 63.176% |
| FDC Limited | 3.7 Billion INR | -279.914% |
| Glenmark Life Sciences Limited | 5.18 Billion INR | -171.995% |
| Gufic Biosciences Limited | 5.59 Billion INR | -151.648% |
| Hikal Limited | 12.99 Billion INR | -8.441% |
| Ind-Swift Laboratories Limited | 2.28 Billion INR | -515.507% |
| Ind-Swift Limited | 13.45 Billion INR | -4.749% |
| Innova Captab Limited | 4.89 Billion INR | -187.595% |
| IOL Chemicals and Pharmaceuticals Limited | 6.32 Billion INR | -122.658% |
| Jagsonpal Pharmaceuticals Limited | 296.76 Million INR | -4648.551% |
| Jubilant Pharmova Limited | 61.27 Billion INR | 77.002% |
| Kilitch Drugs (India) Limited | 643.88 Million INR | -2088.565% |
| Laurus Labs Limited | 42.71 Billion INR | 67.009% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -1211.42% |
| Lupin Limited | 96.23 Billion INR | 85.357% |
| Mangalam Drugs & Organics Limited | 1.97 Billion INR | -613.036% |
| Medico Remedies Limited | 438.24 Million INR | -3115.515% |
| Morepen Laboratories Limited | 4.45 Billion INR | -215.975% |
| Nectar Lifesciences Limited | 11.21 Billion INR | -25.617% |
| Orchid Pharma Limited | 3.84 Billion INR | -266.585% |
| Procter & Gamble Health Limited | 2.56 Billion INR | -450.203% |
| Sigachi Industries Limited | 2.53 Billion INR | -456.71% |
| Sun Pharmaceutical Industries Limited | 183.56 Billion INR | 92.323% |
| Themis Medicare Limited | 1.88 Billion INR | -646.581% |
| Unichem Laboratories Limited | 8.06 Billion INR | -74.636% |
| Vaishali Pharma Limited | 371.16 Million INR | -3696.661% |
| Venus Remedies Limited | 1.39 Billion INR | -911.76% |
| Wanbury Limited | 3.15 Billion INR | -346.577% |
| Windlas Biotech Limited | 1.76 Billion INR | -699.444% |
| ZIM Laboratories Limited | 2.08 Billion INR | -577.242% |
| Sakar Healthcare Limited | 1.26 Billion INR | -1015.493% |
| Aurobindo Pharma Limited | 152.2 Billion INR | 90.742% |
| Divi's Laboratories Limited | 18.99 Billion INR | 25.794% |
| AstraZeneca Pharma India Limited | 3.66 Billion INR | -284.905% |
| Mankind Pharma Limited | 23.87 Billion INR | 40.976% |
| Sequent Scientific Limited | 8.27 Billion INR | -70.309% |
| Neuland Laboratories Limited | 5.49 Billion INR | -156.282% |
| J. B. Chemicals & Pharmaceuticals Limited | 10.7 Billion INR | -31.601% |
| Glenmark Pharmaceuticals Limited | 65.11 Billion INR | 78.357% |
| Zydus Lifesciences Limited | 71.79 Billion INR | 80.371% |
| Amrutanjan Health Care Limited | 783.82 Million INR | -1697.827% |
| Wockhardt Limited | 39.87 Billion INR | 64.656% |
| Bal Pharma Limited | 2.51 Billion INR | -461.141% |
| Dr. Reddy's Laboratories Limited | 106.96 Billion INR | 86.826% |
| Bliss GVS Pharma Limited | 2.1 Billion INR | -568.222% |
| Par Drugs and Chemicals Limited | 159.79 Million INR | -8718.895% |
| Caplin Point Laboratories Limited | 3.5 Billion INR | -301.98% |
| Shilpa Medicare Limited | 12.93 Billion INR | -8.964% |
| Valiant Laboratories Limited | 1.05 Billion INR | -1231.6% |
| Ajanta Pharma Limited | 10.71 Billion INR | -31.572% |
| Aarey Drugs & Pharmaceuticals Limited | 1.72 Billion INR | -718.25% |
| Granules India Limited | 22.95 Billion INR | 38.61% |
| Medicamen Biotech Limited | 940.36 Million INR | -1398.543% |
| Syncom Formulations (India) Limited | 1.16 Billion INR | -1109.378% |
| Piramal Enterprises Limited | 560.47 Billion INR | 97.486% |
| Torrent Pharmaceuticals Limited | 82.05 Billion INR | 82.825% |
| NATCO Pharma Limited | 10.53 Billion INR | -33.8% |
| Suven Life Sciences Limited | 148.62 Million INR | -9381.702% |
| Krebs Biochemicals & Industries Limited | 2.97 Billion INR | -373.847% |
| Strides Pharma Science Limited | 37.68 Billion INR | 62.602% |
| Indoco Remedies Limited | 10.34 Billion INR | -36.254% |
| Alpa Laboratories Limited | 307.12 Million INR | -4488.339% |
| Lasa Supergenerics Limited | 541.92 Million INR | -2500.323% |
| Sun Pharma Advanced Research Company Limited | 3.89 Billion INR | -261.987% |